Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

  • When typing in this field, a list of search results will appear and be automatically updated as you type.

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

Japan's UMI and Yissum Establish Strategic Partnership

Yissum's Racah Nano Venture Fund Surpasses $7M with UMI Investment

Yissum Logo (PRNewsfoto/Yissum)

News provided by

Yissum , UMI

25 Nov, 2019, 09:00 IST

Share this article

Share toX

Share this article

Share toX

JERUSALEM, Nov. 25, 2019 /PRNewswire/ -- Yissum, the Technology Transfer Company of the Hebrew University of Jerusalem, announced today a strategic partnership with Universal Materials Incubator Ltd. (UMI), a 16.5B JPY Investment Fund from Japan. The partnership will focus on commercialization of cutting-edge technologies from Hebrew University (HU) to Japanese corporations. As specialists in materials and chemical industries, UMI has also invested in Yissum's Racah Nano Venture Fund, an investment vehicle founded this year to focus on Hebrew University innovations in advanced materials and nanotechnology.

The strategic partnership allows Yissum and UMI to grow their international presence and facilitate the adaptation of HU technologies to the Japanese market as well as create joint investment opportunities.

CIO of UMI, Dr. Shosuke Kiba said, "Through this collaboration, we aim to strengthen our network in Israel and improve our position as a new business creation platform in the materials and chemical industries in Japan. Israel is a global leader in the startup ecosystem and one of our top international targets for finding investment projects that contribute to the development of the Japanese materials and chemical industries."

Yissum's Senior VP of Business Development and Alliance Management, Dr. Itzik Goldwaser said, "The partnership with UMI advances Yissum's efforts to bring Hebrew University innovations to global markets and furthers our international strategy of global outreach that already includes similar partnerships in China and South America."

The Racah Nano Venture Fund completed its initial closing in July and has now raised over $7 million from top international and strategic investors. The fund's Chief Operating & Technology Officer Avi Voldman said, "The Racah fund aims to leverage Hebrew University's core strengths in advanced materials and nanotechnology. UMI's investment will help ensure the elite status of our technologies in the growing global nanomaterials markets."

About UMI

UMI is a venture capital focusing on chemicals and material science. It was established in October 2015 based on the vision of "Strengthening Japan's technological capabilities by fostering outstanding material and chemical companies and cultivating an industry structure that can compete in the global arena." Currently operating the UMI 1 & 2 Limited Partnership, with 16.5 billion yen in committed capital (from January 2016). For further information please visit www.umi.co.jp/en/.

About Yissum

Yissum is the technology transfer company of The Hebrew University of Jerusalem. Founded in 1964, it is the third company of its kind to be established and serves as a bridge between cutting-edge academic research and a global community of entrepreneurs, investors, and industry. Yissum's mission is to benefit society by converting extraordinary innovations and transformational technologies into commercial solutions that address our most urgent global challenges. Yissum has registered over 10,000 patents covering 2,800 inventions; licensed over 900 technologies and has spun out more than 135 companies. Yissum's business partners span the globe and include companies such as Boston Scientific, Google, ICL, Intel, Johnson & Johnson, Merck, Microsoft, Novartis and many more. For further information please visit www.yissum.co.il

About Racah Nano Venture Fund

Racah Nano Venture Fund is The Hebrew University of Jerusalem's venture fund focused on smart materials and nanotechnology. The nanotech fund was established in 2019 as a unique blend of academia and entrepreneurism to commercially asses and develop the best ideas within the University's walls. Racah Nano Venture Fund is a pro-active initiative which offers funding to university projects, allowing academic researchers to focus on perfecting their research, while also providing  industry with high quality innovations that offer sufficient validation to provide initial de-risking of early-stage investments.

Press Contact: Estee Yaari, [email protected]

SOURCE Yissum; UMI

Modal title

Contact PR Newswire

  • +972-77-2005042
    from 8 AM - 11 PM IL

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Csezh
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italie
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+972-77-2005042
from 8 AM - 11 PM IL
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.